MedGene Therapeutics Publishes Preclinical Data Demonstrating RIV-8’s Ability to Overcome T Cell Exhaustion in the Journal Science Advances
29. November 2022 17:00 ET
|
Medgene Therapeutics, Inc.
GAITHERSBURG, Md., Nov. 29, 2022 (GLOBE NEWSWIRE) -- MedGene Therapeutics, Inc. (MedGene), a biopharmaceutical company dedicated to bringing adoptive cell therapies to solid tumors, today announced...
MATEON ANNOUNCES $2 MILLION FINANCING WITH GOLDEN MOUNTAIN PARTNERS TO CONDUCT CLINICAL TRIAL OF OT-101 AGAINST COVID19
29. Juni 2020 07:00 ET
|
Mateon Therapeutics, Inc.
AGOURA HILLS, Calif., June 29, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (“Mateon” or the “Company”) (OTCQB:MATN) announces it has secured a $2 million in debt financing with Golden...